CD28 and B-cell chronic lymphocytic leukemia: However, in case of CLL, the 4-1BB CARs exhibited superior efficacy than the CD28 CARs, probably due to increased persistence of 4-1BB (CD137) CAR T cells and exhaustion of CD28 CAR T cells driven by CD28 endodomain signaling (46, 50, 51).